Elizabeth Migoya
- Infectious Diseases top 10%
- Antifungal resistance and susceptibility 4
- Small Animals top 5%
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism 3
- Antibiotics Pharmacokinetics and Efficacy 3
-
- Diabetes Treatment and Management 4
-
- Pharmaceutical studies and practices 5
-
- Estrogen and related hormone effects 4
-
- Nematode management and characterization studies 3
-
- Prostate Cancer Treatment and Research 3
- Co-authors
- Kenneth C. LasseterPaul DeutschStacy C. DilzerJulie A. StoneGregory A. WinchellBarbara KnorrGoutam C. MistrySheng Bi
- Journals
- Journal of Clinical Oncology (1 paper)Gastroenterology (1 paper)Antimicrobial Agents and Chemotherapy (2 papers)
- Partner nations
- United StatesUnited KingdomSwitzerland
In The Last Decade
Elizabeth Migoya
27 papers receiving 531 citations
Peers
Comparison fields: 5 of 74
- Infectious Diseases 235
- Applied Microbiology and Biotechnology 19
- Small Animals 69
- Pharmacology 139
- Endocrinology, Diabetes and Metabolism 100
Countries citing papers authored by Elizabeth Migoya
This map shows the geographic impact of Elizabeth Migoya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Migoya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Migoya more than expected).
Fields of papers citing papers by Elizabeth Migoya
This network shows the impact of papers produced by Elizabeth Migoya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Migoya. The network helps show where Elizabeth Migoya may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Elizabeth Migoya, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 7 | |
| 2 | 2023 | 7 | |
| 3 | 2023 | 6 | |
| 4 | 2022 | 12 | |
| 5 | 2022 | 8 | |
| 6 | 2020 | 3 | |
| 7 | 2020 | 4 | |
| 8 | 2019 | 22 | |
| 9 | 2016 | 4 | |
| 10 | 2011 | 8 | |
| 11 | 2010 | 7 | |
| 12 | 2010 | 27 | |
| 13 | 2010 | 18 | |
| 14 | 2008 | 20 | |
| 15 | 2006 | 26 | |
| 16 | 2006 | 1 | |
| 17 | 2005 | 19 | |
| 18 | 2004 | 34 | |
| 19 | 2004 | 111 | |
| 20 | 2000 | 9 |
About Elizabeth Migoya
Elizabeth Migoya is a scholar working on Reproductive Medicine, Family Practice and Endocrinology, Diabetes and Metabolism, having authored 27 papers that have together received 561 indexed citations. Recurring topics across this work include Pharmaceutical studies and practices (5 papers), Antifungal resistance and susceptibility (4 papers), Estrogen and related hormone effects (4 papers), Diabetes Treatment and Management (4 papers), Nematode management and characterization studies (3 papers), Pharmacogenetics and Drug Metabolism (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Prostate Cancer Treatment and Research (3 papers). The work is most often cited by research in Infectious Diseases (235 citations), Applied Microbiology and Biotechnology (19 citations) and Small Animals (69 citations). Elizabeth Migoya has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Kenneth C. Lasseter, Paul Deutsch, Stacy C. Dilzer, Julie A. Stone, Gregory A. Winchell, Barbara Knorr, Goutam C. Mistry, Sheng Bi, Gregory L. Kearns and Rohini Ramakrishnan. Their work appears in journals such as Journal of Clinical Oncology, Gastroenterology and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.